Eleven Biotherapeutics, Inc. 4
4 · Eleven Biotherapeutics, Inc. · Filed Jul 12, 2016
Insider Transaction Report
Form 4
MCCABE JOHN J
Senior Vice President, Finance
Transactions
- Award
Stock Option (Right to Buy)
2016-07-09+6,664→ 13,336 totalExercise: $0.28From: 2016-07-09Exp: 2026-02-24→ Common Stock (6,664 underlying)
Footnotes (1)
- [F1]On February 25, 2016, the reporting person was granted an option to purchase 20,000 shares of common stock. This option vests in installments based on the achievement of certain regulatory and business milestones. The Compensation Committee of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 6,664 shares. The option had previously vested with respect to 6,672 shares.